Recent advances in triple negative breast cancer: the immunotherapy era https://t.co/a6ZAsNJ7dS https://t.co/zd2QoY8dwY
1,079 followers
0 followers
Recent advances in triple negative breast cancer: the immunotherapy era. https://t.co/4iilc0ys1d
861 followers
RT @TeamImugene: Our first trial kicking off in 2020 will be CheckVacc an oncolytic virus CF33 armed with an immunotherapeutic PD-L1 inhibi…
3,227 followers
Our first trial kicking off in 2020 will be CheckVacc an oncolytic virus CF33 armed with an immunotherapeutic PD-L1 inhibiting checkpoint inhibitor. Learn more in this article about the dawn of the immunotherapy era for TNBC #cancer #breastcancer #ASX $IMU